Therapeutic strategies in Parkinson's disease: what we have learned from animal models

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/nyas.12577PMID 25515068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of Parkinson's disease

  2016cited by this paper
• Improving Response Inhibition in Parkinson’s Disease with Atomoxetine

  2015cited by this paper
• The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy

  2014cited by this paper
• Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease.

  2014cited by this paper
• The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease

  2014cited by this paper
• LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?

  2014cited by this paper
• PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling

  2014cited by this paper
• Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 Domain

  2014cited by this paper
• The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy

  2014cited by this paper
• Endophilin A1 induces different membrane shapes using a conformational switch that is regulated by phosphorylation

  2014cited by this paper
• α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration

  2014cited by this paper
• Modeling dyskinesia in animal models of Parkinson disease.

  2014cited by this paper
• Parkin and PINK1: much more than mitophagy.

  2014cited by this paper
• Ret rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants

  2014cited by this paper
• In vitro aggregation assays for the characterization of α-synuclein prion-like properties

  2014cited by this paper
• Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlates.

  2014cited by this paper
• A special focus issue on the materials of PRION 2013 meeting in Banff, Alberta Canada

  2014cited by this paper
• Parkin and mitochondrial quality control: toward assembling the puzzle.

  2014cited by this paper
• Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.

  2014cited by this paper
• Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2

  2013cited by this paper
• The role of mitochondrial function and cellular bioenergetics in ageing and disease

  2013cited by this paper
• Parkinson's Disease: From Genetics to Treatments

  2013cited by this paper
• Mutations in the intellectual disability gene Ube2a cause neuronal dysfunction and impair parkin-dependent mitophagy.

  2013cited by this paper
• Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.

  2013cited by this paper
• Parthanatos Mediates AIMP2 Activated Age Dependent Dopaminergic Neuronal Loss

  2013cited by this paper
• Chaperone-mediated autophagy: roles in disease and aging

  2013cited by this paper
• Interplay of LRRK2 with chaperone-mediated autophagy

  2013cited by this paper
• Aconitase Causes Iron Toxicity in Drosophila pink1 Mutants

  2013cited by this paper
• [Epidemiology of Parkinson's disease].

  2013cited by this paper
• LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25

  2013cited by this paper
• Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early‐Onset Parkinsonism

  2013cited by this paper
• Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

  2013cited by this paper
• Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies

  2013cited by this paper
• Near-Infrared 808 nm Light Boosts Complex IV-Dependent Respiration and Rescues a Parkinson-Related pink1 Model

  2013cited by this paper
• The Sac1 Domain of SYNJ1 Identified Mutated in a Family with Early‐Onset Progressive Parkinsonism with Generalized Seizures

  2013cited by this paper
• Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease

  2013cited by this paper
• Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration

  2012cited by this paper
• Vitamin K2 Is a Mitochondrial Electron Carrier That Rescues Pink1 Deficiency

  2012cited by this paper
• Alpha-synuclein: from secretion to dysfunction and death

  2012cited by this paper
• The synaptic function of LRRK2.

  2012cited by this paper
• Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1

  2012cited by this paper
• Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities

  2012cited by this paper
• LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.

  2012cited by this paper
• parkin-induced defects in neurophysiology and locomotion are generated by metabolic dysfunction and not oxidative stress

  2012cited by this paper
• The Yeast Complex I Equivalent NADH Dehydrogenase Rescues pink1 Mutants

  2012cited by this paper
• Prion-like acceleration of a synucleinopathy in a transgenic mouse model.

  2012cited by this paper
• A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice

  2012cited by this paper
• Modeling Parkinson's disease in primates: The MPTP model.

  2012cited by this paper
• α-synuclein, LRRK2 and their interplay in Parkinson's disease.

  2012cited by this paper
• Genetics of Parkinson's disease.

  2012cited by this paper
• Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models

  2012cited by this paper
• Defective Autophagy in Parkinson’s Disease: Role of Oxidative Stress

  2012cited by this paper
• Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission

  2012cited by this paper
• Synaptic dysfunction in Parkinson's disease.

  2012cited by this paper
• Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation

  2012cited by this paper
• Α-synuclein misfolding and Parkinson's disease.

  2012cited by this paper
• Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo

  2012cited by this paper
• Use of viral vectors to create animal models for Parkinson's disease.

  2012cited by this paper
• Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

  2012cited by this paper
• Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease

  2012cited by this paper
• Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease

  2011cited by this paper
• Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2

  2011cited by this paper
• Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL/6 mice.

  2011cited by this paper
• Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission

  2011cited by this paper
• Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease

  2011cited by this paper
• Recent advances in the genetics of Parkinson's disease.

  2011cited by this paper
• LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool

  2011cited by this paper
• Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

  2011cited by this paper
• Broad activation of the ubiquitin–proteasome system by Parkin is critical for mitophagy

  2011cited by this paper
• Parkin Mediates Proteasome-dependent Protein Degradation and Rupture of the Outer Mitochondrial Membrane*♦

  2011cited by this paper
• The role of α-synuclein in neurotransmission and synaptic plasticity.

  2011cited by this paper
• PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.

  2011cited by this paper
• Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina.

  2011cited by this paper
• Rotenone, Paraquat, and Parkinson’s Disease

  2011cited by this paper
• Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease

  2011cited by this paper
• What genetics tells us about the causes and mechanisms of Parkinson's disease.

  2011cited by this paper
• Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction

  2010cited by this paper
• A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease

  2010cited by this paper
• α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro

  2010cited by this paper
• Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease.

  2010cited by this paper
• Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.

  2010cited by this paper
• The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of the PINK1/Parkin Pathway

  2010cited by this paper
• Increased Expression of a-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis

  2010cited by this paper
• SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.

  2010cited by this paper
• Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S

  2010cited by this paper
• Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin

  2010cited by this paper
• Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

  2010cited by this paper
• Synaptic Mitochondria in Synaptic Transmission and Organization of Vesicle Pools in Health and Disease

  2010cited by this paper
• DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function

  2010cited by this paper
• Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function

  2010cited by this paper
• Identification of novel genes involved in synaptic communication

  2010cited by this paper
• Tonicity-dependent induction of Sgk1 expression has a potential role in dehydration-induced natriuresis in rodents.

  2009cited by this paper
• Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.

  2009cited by this paper
• Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.

  2009cited by this paper
• Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response

  2009cited by this paper
• Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin

  2009cited by this paper
• LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.

  2009cited by this paper
• Principles and Practice of Movement Disorders

  2009cited by this paper
• Effects of UCH‐L1 on α‐synuclein over‐expression mouse model of Parkinson’s disease

  2009cited by this paper
• α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

  2009cited by this paper

• Trends in parkinson’s disease mortality in China from 2004 to 2021: a joinpoint analysis

  2024cites this paper
• Mitochondrial DNA D-loop SNPs unveil molecular signatures of milk production variation in Murrah buffalo

  2024cites this paper
• Role of ceramides and sphingolipidsin Parkinson's disease.

  2023cites this paper
• Association analysis of mitochondrial genome polymorphisms with backfat thickness in pigs

  2023cites this paper
• Neurodegenerative Disorders: Spotlight on Sphingolipids

  2021cites this paper
• Animal models of synucleinopathies and how they could impact future drug discovery and delivery efforts

  2019cites this paper
• Role of Autophagy in Parkinson's Disease.

  2019cites this paper
• Sleep dysfunction in Parkinson's disease: Novel molecular mechanism and implications for therapy

  2018cites this paper
• p13 protects against Parkinson's disease

  2018cites this paper
• Inhibition of oxidative stress in cholinergic projection neurons fully rescues aging-associated olfactory circuit degeneration in Drosophila

  2018cites this paper
• Induced pluripotent stem cells in rat models of Parkinson's disease: A systematic review and meta-analysis.

  2018cites this paper
• ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson's Disease.

  2018cites this paper
• Parkinson’s disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons

  2018cites this paper
• Parkinson’s disease-linked Parkin mutations impair glutamatergic synaptic transmission and plasticity

  2018cites this paper
• Developing DNA methylation-based diagnostic biomarkers.

  2018cites this paper
• Neuroprotective effects of TUDCA in Parkinson’s disease: dissecting the anti-oxidant and anti-inflammatory effects of this bile acid in the mouse cerebral cortex

  2017cites this paper
• Characterization of FBXO7 (PARK15) knockout mice modeling Parkinsonian-Pyramidal Syndrome

  2017cites this paper
• The Neurogenetics of Parkinson’s Disease and Putative Links to Other Neurodegenerative Disorders

  2017cites this paper
• Measuring Changes in Brain Manganese or Iron Using Magnetic Resonance Imaging (MRI)

  2017cites this paper
• Differential Diagnosis of Parkinson ’ s Disease and Atypical Parkinsonian Syndromes Parkinson

  2017cites this paper
• [Autophagy pathways and key drug targets in Parkinson's disease].

  2016cites this paper
• Genetic analysis of MC1R variants in Chinese Han patients with sporadic Parkinson's disease.

  2016cites this paper
• Emerging preclinical pharmacological targets for Parkinson's disease

  2016cites this paper
• Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s Disease

  2016cites this paper
• Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model.

  2016cites this paper
• Systematic analysis of genetic variants in Han Chinese patients with sporadic Parkinson’s disease

  2016cites this paper
• β-Ecdysterone Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Apoptosis via Mitochondria-Dependent Mechanism: Involvement of p38MAPK–p53 Signaling Pathway

  2016cites this paper
• Induced pluripotent stem cells and Parkinson's disease: modelling and treatment

  2016cites this paper
• Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson's disease patients.

  2016cites this paper
• pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson ' s disease model

  2015cites this paper
• Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose

  2015cites this paper
• Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson’s Disease

  2015influential citation
• Anti-Parkinson Activity

  2015cites this paper
• Mitochondria: A Therapeutic Target for Parkinson’s Disease?

  2015cites this paper
• Role of the orphan receptor GPR88 in psychiatric and motor disorders

  2015cites this paper
• TCEANC2 rs10788972 and rs12046178 variants in the PARK10 region in Chinese Han patients with sporadic Parkinson's disease.

  2015cites this paper
• Becker Digital Commons

  year unknowncites this paper
• DNA modifications in genome : cytosine modifications and beyond

  year unknowncites this paper